Cargando…
Patients with checkpoint inhibitor‐induced inflammatory arthritis do not become seropositive for anti‐cyclic citrullinated peptide when followed over time
Autores principales: | Cappelli, Laura C., Darrah, Erika, Shah, Ami A., Bingham, Clifton O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754020/ https://www.ncbi.nlm.nih.gov/pubmed/34757698 http://dx.doi.org/10.1002/acr2.11363 |
Ejemplares similares
-
Anti-RA33 antibodies are present in a subset of patients with immune checkpoint inhibitor-induced inflammatory arthritis
por: Cappelli, Laura C, et al.
Publicado: (2022) -
Time to Include Fine Specificity Anti‐Citrullinated Protein Antibodies in the Routine Diagnosis and Management of Rheumatoid Arthritis?
por: Schwenzer, Anja, et al.
Publicado: (2019) -
Sonographic Findings in Inflammatory Arthritis Secondary to Immune Checkpoint Inhibition: A Case Series
por: Albayda, Jemima, et al.
Publicado: (2019) -
Citrullination modulates antigen processing and presentation by revealing cryptic epitopes in rheumatoid arthritis
por: Curran, Ashley M., et al.
Publicado: (2023) -
Smoking is not linked to the development of anti-peptidylarginine deiminase 4 autoantibodies in rheumatoid arthritis
por: Cappelli, Laura C., et al.
Publicado: (2018)